| Name | Title | Contact Details |
|---|
Surgical Orthomedics, Inc. is a Pantego, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bone Biologics was founded by University of California Los Angeles professors in collaboration with an Osaka University professor, and a USC surgeon in 2004. Formed to pursue regenerative medicine for bone, the company currently has as its strategic partners the Musculoskeletal Transplant Foundation, the nation's leading tissue bank and Orthofix, a leading global medical device company. Bone Biologics is currently focused on bone regeneration in spinal fusion using its recombinant human protein known as Nell-1. Nell-1 is an osteoinductive orthobiologic; a recombinant protein that provides control over bone regeneration. This patent protected technology has been exclusively licensed to Bone Biologics from UCLA.
IDEX Health & Science is the global authority in fluidics and optics` bringing life to advanced optofluidic technologies with our products` people and engineering expertise. We are respected worldwide for solving complex problems and delivering complete path innovation for analytical` diagnostic and biotechnology applications for the life sciences market. As a genuine and trustworthy partner` we solve our customers’ most demanding challenges with the industry`s most extensive portfolio of state-of-the-art components and capabilities that are unrivaled in breadth` quality` performance and design. Our vision of the complete path goes far beyond just meeting our customers’ needs — it anticipates them` with intelligent solutions for life.
medi part inc is a Cary, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.